KENDALL DORIE: Open Payments
NPI 1164081253 · PIEDMONT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 25 payments from 14 companies in 2025. Trend: 2023 $1,055 · 2024 $887 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 2 | $203 |
| Janssen Pharmaceuticals, Inc | 1 | $77 |
| ABBVIE INC. | 4 | $71 |
| Braeburn Inc. | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| HARMONY BIOSCIENCES LLC | 1 | $32 |
Products named: SPRAVATO, VRAYLAR, BRIXADI, HETLIOZ, VIVITROL, The Cologuard Plus Collection Kit, CAPLYTA, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
